Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Rebel HG"'
Autor:
van Vliet Ej, Hans Clevers, Wehrens Ej, Alieva M, Oded Kopper, Rebel Hg, Kai Kretzschmar, A. D. Meringa, Rios Ac, Yotam E. Bar-Ephraim, van Ineveld Rl, Peter Brazda, Domenico Fasci, Ariese Hc, Farid Keramati, Inez Johanna, Buchholz M, Henk Stunnenberg, Johanna F. Dekkers, J. Kuball, Karaiskaki E, Eggermont Am, Zsolt Sebestyén, Wezenaar Ak, Maarten H. Geurts, Román Mb, Jens Puschhof, Cleven A
SummaryCellular immunotherapies are rapidly gaining clinical importance, yet predictive platforms for modeling their mode of action are lacking. Here, we developed a dynamic immuno-organoid 3D imaging-transcriptomics platform; BEHAV3D, to unravel the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a3449ee2bfa7051e711bd3325bf3838
https://doi.org/10.1101/2021.05.05.442764
https://doi.org/10.1101/2021.05.05.442764
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Dekkers JF; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Alieva M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cleven A; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Keramati F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Wezenaar AKL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Vliet EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Puschhof J; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Microbiome and Cancer Division, German Cancer Research Center, Heidelberg, Germany., Brazda P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Johanna I; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Meringa AD; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rebel HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Buchholz MB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Barrera Román M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeeman AL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., de Blank S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Fasci D; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Geurts MH; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Cornel AM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Driehuis E; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Millen R; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Straetemans T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Nicolasen MJT; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Aarts-Riemens T; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Ariese HCR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Johnson HR; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., van Ineveld RL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Karaiskaki F; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Kopper O; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Bar-Ephraim YE; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Kretzschmar K; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Mildred Scheel Early Career Center for Cancer Research Würzburg, University Hospital Würzburg, MSNZ/IZKF, Wurzburg, Germany., Eggermont AMM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands.; Comprehensive Cancer Center München, Munich, Germany., Nierkens S; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Wehrens EJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Stunnenberg HG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Clevers H; Hubrecht Institute, Royal Netherlands Academy of Arts and Sciences and University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Pharma, Research and Early Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kuball J; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Department of Hematology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Sebestyen Z; Center for Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., Rios AC; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. a.c.rios@prinsesmaximacentrum.nl.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2023 Jan; Vol. 41 (1), pp. 60-69. Date of Electronic Publication: 2022 Jul 25.
Autor:
Bayley JP; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands., Rebel HG; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands., Scheurwater K; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands., Duesman D; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands., Zhang J; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands., Schiavi F; Veneto Institute of Oncology, University of Padova, Padova, Italy., Korpershoek E; Department of Pathology, Josephine Nefkens Institute, Erasmus MC, Rotterdam, The Netherlands., Jansen JC; Department of Otorhinolaryngology/Head and Neck Surgery, Leiden University Medical Center, Leiden, The Netherlands., Schepers A; Department of Internal Medicine, Leiden University Medical Centre, Leiden, The Netherlands., Devilee P; Department of Human Genetics, Leiden University Medical Centre, Leiden, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Publikováno v:
PloS one [PLoS One] 2022 Sep 30; Vol. 17 (9), pp. e0274478. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).